ScholarIQanswers from OpenAlex & ORCID
Takahito Moriyama
ResearcherPublications, citations & collaboration network
Takahito Moriyama is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Takahito Moriyama have?
ScholarIQindexed works
Takahito Moriyama has 154 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Takahito Moriyama have?
ScholarIQcitation count
Takahito Moriyama has 2,205 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Takahito Moriyama?
ScholarIQh-index
Takahito Moriyama has an h-index of 26 in OpenAlex.
What is the i10-index of Takahito Moriyama?
ScholarIQi10-index
Takahito Moriyama has an i10-index of 64 in OpenAlex.
What is the ORCID of Takahito Moriyama?
ScholarIQorcid
The ORCID for Takahito Moriyama is on the source record.
What is the OpenAlex record for Takahito Moriyama?
ScholarIQopenalex
The OpenAlex for Takahito Moriyama is on the source record.
What are the most-cited papers on Takahito Moriyama?
ScholarIQmost cited works
Prognosis in IgA Nephropathy: 30-Year Analysis of 1,012 Patients at a Single Center in Japan
Takahito Moriyama, Kayu Tanaka, Chihiro Iwasaki, Yasuko Oshima, Ayami Ochi, Hiroshi Kataoka, Mitsuyo Itabashi, Takashi Takei, Keiko Uchida, Kosaku Nitta
Caveolar Endocytosis Is Critical for BK Virus Infection of Human Renal Proximal Tubular Epithelial Cells
Takahito Moriyama, J. Pablo Marquez, Tetsuro Wakatsuki, Andrey Sorokin
Effect of single-dose rituximab on steroid-dependent minimal-change nephrotic syndrome in adults
Takashi Takei, Mitsuyo Itabashi, Takahito Moriyama, Chiari Kojima, S. Shiohira, Ari Shimizu, Yuki Tsuruta, Atsuhiko Ochi, N Amemiya, Toshio Mochizuki, Keiko Uchida, K. Tsuchiya, Kosaku Nitta
Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation
Takahito Moriyama, Kosaku Nitta, Koichi Suzuki, Kazuho Honda, Shigeru Horita, Keiko Uchida, Wako Yumura, Kazunari Tanabe, Hiroshi Toma, Hiroshi Nihei, Yutaka Yamaguchi
Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease
Yuki Tsuruta, Toshio Mochizuki, Takahito Moriyama, Mitsuyo Itabashi, Takashi Takei, Ken Tsuchiya, Kosaku Nitta